DarioHealth Corp. (DRIO)

Market Cap	54.88M
Revenue (ttm)	19.04M
Net Income (ttm)	-59.90M
Shares Out	29.67M
EPS (ttm)	-1.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	425,830
Open	1.640
Previous Close	1.730
Day's Range	1.560 - 1.870
52-Week Range	0.680 - 4.580
Beta	1.65
Analysts	Strong Buy
Price Target	4.05 (+118.92%)
Earnings Date	May 15, 2024

About DRIO

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, wh...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2011
• Employees: 276
• Stock Exchange: NASDAQ
• Ticker Symbol: DRIO

Financial Performance

In 2023, DarioHealth's revenue was $20.35 million, a decrease of -26.41% compared to the previous year's $27.66 million. Losses were -$63.51 million, -0.51% less than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price forecast is $4.05, which is an increase of 118.92% from the latest price.

Price Target

$4.05

(118.92% upside)

Analyst Consensus: Strong Buy